计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| C650686-1mg |
1mg |
期货 ![]() |
| |
| C650686-5mg |
5mg |
期货 ![]() |
| |
| C650686-10mg |
10mg |
期货 ![]() |
| |
| C650686-50mg |
50mg |
期货 ![]() |
|
| 别名 | CCR2 拮抗剂 1 |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | CCR2 antagonist 1 |
| 生化机理 | CCR2 拮抗剂 1 是一种高亲和力、长驻留时间的 CCR2 拮抗剂,其 K i 为 2.4 nM。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
CCR2 antagonist 1 is a high-affinity and long-residence-time CCR2 antagonist, with a K i of 2.4 nM. In Vitro The combination of SAR and SKR in the hit-to-lead process results in the discovery of a new higheaffinity and longeresidenceetime CCR2 antagonist (CCR2 antagonist 1 (compound 15a), K i =2.4 nM; RT=714 min). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:CCR2 2.4 nM (Ki) |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IUPAC Name | [(1S,3R)-3-[[(1R)-5-bromo-2,3-dihydro-1H-inden-1-yl]amino]-1-propan-2-ylcyclopentyl]-[7-(trifluoromethyl)-3,4-dihydro-1H-isoquinolin-2-yl]methanone |
| INCHI | InChI=1S/C28H32BrF3N2O/c1-17(2)27(11-9-23(15-27)33-25-8-4-19-14-22(29)6-7-24(19)25)26(35)34-12-10-18-3-5-21(28(30,31)32)13-20(18)16-34/h3,5-7,13-14,17,23,25,33H,4,8-12,15-16H2,1-2H3/t23-,25-,27+/m1/s1 |
| InChi Key | QYDUEIJZRKTNKN-HYZYYIOASA-N |
| Canonical SMILES | CC(C)C1(CCC(C1)NC2CCC3=C2C=CC(=C3)Br)C(=O)N4CCC5=C(C4)C=C(C=C5)C(F)(F)F |
| Isomeric SMILES | CC(C)[C@@]1(CC[C@H](C1)N[C@@H]2CCC3=C2C=CC(=C3)Br)C(=O)N4CCC5=C(C4)C=C(C=C5)C(F)(F)F |
| PubChem CID | 73334813 |
| 分子量 | 549.47 |
| 溶解性 | DMSO : 125 mg/mL (227.49 mM; Need ultrasonic) |
|---|